No Data
A-share movement | From today onwards, 'ST Lighten' start trading with a 'cap', ST Guandian fell 20cm limit down during the session.
格隆汇November 4th | Drone service provider special treat Vision(688287.SH) resumed trading and once dropped by 20cm, now trading at 5.07 yuan, with a total market value of less than 2 billion yuan. In terms of news, the company resumed trading today and implemented other risk warnings from the date of resumption, and the A-share abbreviation after resumption is special treat Vision. The company's stock price limit remains unchanged at 20%. The company's self-inspection found that as of May 29, 2024, the actual controller has not returned a total of 159.1852 million yuan, constituting the actual controller and its related parties' occupation of funds of the listed company, accounting for the mother net assets of the company's most recent period audited
Guandian Defense (688287.SH) stocks will be subject to other risk alerts.
Observation Defense (688287.SH) announcement, the company found in self-inspection that, as of May 29, 2024, the actual control...
Express News | Watch Defense: The security abbreviation has been changed to special treat Watch Defense. Stocks will be suspended from trading tomorrow.
A股异动丨Guandian Defense fell more than 8%, performance loss + risk warning
October 29th by Gelunhui | Drone service provider Guandian Defence (688287.SH) is now down 8.3%, at 6 yuan, with a total market value of 2.25 billion yuan. The company announced yesterday evening that it achieved revenue of 74.26 million yuan in the first three quarters, a year-on-year decrease of 56.28%; net income attributable to the parent company was a loss of 60.81 million yuan; non-GAAP net loss was 64.62 million yuan. In addition, the controlling party's funds occupy 0.149 billion yuan, and the company's stock trading may be subject to other risk warnings. (Gelunhui)
October 29th A-share investment lightning rod︱West Pharmaceutical: Shareholders China National Pharmaceutical Group and Hangzhou Chuanhe plan to jointly reduce their shareholding by no more than 3%.
Xidian Pharmaceutical shareholders Guotou Gaokai and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%; Tangde Film shareholders Dongyang Juwen plan to reduce their shareholding by no more than 2%; Hualv Biotech shareholders Gaotou Development plan to reduce their shareholding by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their shareholding by no more than 3.34%; Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of case filing
Gudian Defense: Third Quarter Report 2024
No Data
No Data